Articles

Plus: A partnership with Astera Institute and our first job posting.

A look inside FutureHouse, a nonprofit research institute in San Francisco.

Lenacapavir — a long-acting, injectable drug — may be our strongest tool yet to curb HIV, provided it reaches those who need it most.

A new AI model for biology, released today by Arc Institute and NVIDIA, can predict which mutations within a gene are likely to be harmful and even design small, eukaryotic genomes.

Researchers at the Institute for Protein Design have made a computationally-designed, multi-step enzyme.

Works in Progress and Asimov Press are launching a paid six-month fellowship.